Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
In this newly created role, Mr. Walsh will be responsible for business development, including strategic partnering opportunities, and will become part of the executive management team of Immunic.
- In this newly created role, Mr. Walsh will be responsible for business development, including strategic partnering opportunities, and will become part of the executive management team of Immunic.
- "Patrick is a seasoned business development executive who has spent his career helping to successfully build a number of public biopharmaceutical companies.
- He brings to Immunic extensive leadership in building companies through strategic partnerships and non-dilutive funding," stated Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic.
- Mr. Walsh was previously in Corporate Development at AVEO Oncology, during which time he worked on all aspects of business development.